Ebola Treatments Would Qualify For FDA Priority Review Under Bill Passed By Senate Committee
The Hill: Senate panel passes measure to speed up approval of Ebola drugs
“The Senate Health, Education, Labor and Pensions (HELP) Committee approved a measure Wednesday designed to speed the approval of Ebola drugs. The bill (S 2917) would make Ebola treatments eligible for priority review vouchers at the Food and Drug Administration (FDA), cutting down on the evaluation time taken by regulators…” (Viebeck, 11/19).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.